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Volume 54, Number 2 Abstracts 591.0001). On multivariate analysis, the strongest independent predictor for
transfer remained nonmetropolitan hospital (Table). The West had the
lowest likelihood of transfer compared to other regions and the highest
likelihood of ED death (odds ratio [OR], 1.91, 95% confidence interval
[CI], 1.19-3.08; P  .008).
Conclusions:Transfer is rarely used for treatment of rAAA. Higher ED
deaths at hospitals with lower likelihood of transfer suggest that better
transfer protocols may improve survival for patients who present to hospital
EDs with insufficient resources to provide local care.
Table. Predictors of transfer for rAAA
Factor
Adjusted
OR 95% CI P value
Non-metropolitan
hospital 24.4 9.6–62.5  .0001
Non-trauma hospital 10.0 4.9–20.7  .0001
Region
East 4.1 1.3–12.6 .0002
South 6.8 2.5–18.0 .0001
Midwest 6.4 2.4–17.2 .0003
West 1.0 NA Referent
Age (per decade) 0.72 0.58–0.88 .002
CI, Confidence interval; OR, odds ratio.
The Use of Sartorius Muscle Rotational Flaps for Groin Complications
after Vascular Reconstruction
Christian Ochoa, MD, Vahagn Nikolian, Sarah Wartman, MD, William Lee,
MD, Fred A. Weaver, MD, and Vincent Rowe, MD, Department of Vascular
Surgery, University of Southern California, Los Angeles, Calif.
Objectives: Sartorius myoplasty has been shown to be an adequate
adjunct for soft tissue coverage in vascular groin infections. However, in the
era of antibiotic resistant bacterial infections, the durability of the sartorius
myoplasty has been questioned. It is the purpose of this study to determine
whether sartorius myoplasty is a durable option for wound complications
after vascular reconstruction.
Methods: The medical records of all patients undergoing sartorius
myoplasty from 1997 to 2010 were reviewed. Failure of sartorius myoplasty
was defined as operative reintervention for bleeding, persistent wound
drainage, and infection. The 2 and Mann-Whitney U statistics were per-
formed, with a P  .05.
Results: A total of 69 patients underwent sartorius myoplasty during
the study period. Forty-two patients were female and 27 were male and the
average age was 68 years old. Fifty-four percent of the patients had previous
infrainguinal reconstruction. Presenting symptoms included fever in 19%,
sepsis in 8%, pseudoaneurysm in 15%, acute leg ischemia in 22%, and
presence of a foot wound in 25%. Fifty-nine percent of the patients presented
with wound drainage. Intraoperative wound cultures consisted of methicil-
lin sensitive Staphylococcus (39%), methicillin-resistant Staphylococcus (34%),
Enterococcus (35%), Pseudomonas aeruginosa (13%), E. Coli (15%), and
polymicrobial (32%). The failure rate for sartorius myoplasty was 10.1%. For
those patients who failed, a total of 4 had persistent bleeding, 2 patients had
recurrent wound infections requiring redebridement and 1 patient had
necrotizing fasciitis. Univariate analysis found that admission white blood
cell (WBC) count to be a significant factor in those patients who failed
sartorius myoplasty (failed-WBC 18 vs nonfailure WBC 10.2; P  .027).
The presence of wound drainage and microbacteria did not have a significant
effect on the failure of sartorius myoplasty.
Conclusions: In the current setting, sartorius myoplasty provides
reliable soft tissue coverage for vascular groin infections.
Accreditation Council for Continuing Medical Education (ACCME):
The data presented in this abstract demonstrates that in patients with groin
infections, the placement of a muscle flap can impact wound healing and
prove to be a durable method. The treatment gap in this setting is between
wound vac placement vs muscle flap coverage.
No Increased Mortality with Early Aortic Aneurysm Disease
Matthew Mell, MD, Julie J. White, BS, Bradley B. Hill, MD, and Ronald L.
Dalman, MD, Department of Surgery, Stanford University, Stanford, Calif.
Objective: In addition to increased risks for aneurysm-related death,
previous studies have determined that all-cause mortality in patients with
abdominal aortic aneurysms was excessive and equivalent to that associated
with coronary heart disease (CHD). These studies largely preceded the
current era of CHD risk factor management, however, no recent study has
examined contemporary mortality associated with early AAA disease (aneu-
V
lysm diameter between 3 and 5 cm). As part of an ongoing natural history
tudy of AAAs, we report the mortality risk associated with the presence of
arly disease.
Methods: Participants were recruited from three distinct health care
ystems in Northern California between 2006 and 2011. Aneurysm diame-
er, demographic information, comorbidities, medication history, and
lasma for biomarker analysis were collected at study entry. Survival status
as determined at follow-up. Data were analyzed with t test or 2 test where
ppropriate. Freedom from death was calculated via Cox proportional
azards modeling; the relevance of individual predictors on mortality was
etermined by log-rank test.
Results: The study enrolled 645 patients with AAAs; aged 76.5 
.0 years old, and aortic diameter 3.9  0.7 cm. Participants were mostly
en (88.8%), nonsmokers (81.8%), and taking statins (76.7%). Mean
ollow-up was 2.1 1.0 years. Estimated 1-year and 3-year mortality was
nly 1.7 and 5.3%, respectively. Factors independently associated with
ortality included larger aneurysm size (hazard ratio [HR], 2.67; 95%
onfidence interval [CI], 1.26-5.70 for diameter 4.0 cm), and diabetes
HR 2.75; 95% CI, 1.30-5.82). After adjusting for patient-level factors,
he health care system independently predicted mortality: institution 2 vs
(HR, 2.34; 95% CI, .93-5.90); institution 3 vs 1 (HR, 2.61; 95% CI,
.13-6.06).
Conclusions: Contemporary all-cause mortality for patients with early
AA disease is lower than that previously reported, and currently approxi-
ates adjusted mortality for the population at large. Despite this overall
mprovement, however, mortality rates for similar patients vary between
ifferent health care systems within the same region. Further research is
arranted to determine institutional factors that contribute to disparate
urvival in early AAA disease.
orrelation of CEAP Clinical Class, Venous Clinical Severity Scores,
ein Diameter, and Reflux Time in the Great Saphenous Vein in
atients with Superficial Venous Insufficiency
atthew M. Wise, BS, RVT, and Kathleen D. Gibson, MD, Lake Washing-
on Vascular Surgeons and Vascular Laboratories, Bellevue, Wash.
Objective: With the advent of minimally invasive techniques to treat
uperficial venous insufficiency, the volume of varicose vein procedures
erformed in the United States has increased substantially. Insurers are
tarting to utilize specific duplex-derived measures (specifically great
aphenous vein [GSV] diameter and reflux time) to approve or deny
overage of these procedures. The purpose of this study was to assess the
elationship between physician-derived CEAP clinical class, venous clin-
cal severity score (VCSS), and quantitative data obtained from duplex
ltrasound scan.
Methods: A retrospective analysis was performed on all patients
ho underwent a duplex ultrasound scan for venous reflux/venous stasis
isease over a 7-month period (n  739) at a single outpatient vascular
aboratory. For the purposes of this study, we included only those
atients with documented saphenofemoral junction reflux. Patients with
xtensive deep vein reflux, deep vein thrombosis, and superficial throm-
ophlebitis were also excluded. Three hundred seventy patients met this
riteria, and all had diameter and reflux times measured at the saphe-
ofemoral junction/proximal thigh. Two hundred thirty-nine of the 370
atients had documented CEAP and VCSS scores. Pearson correlation
oefficients were used to assess the correlation between GSV diameter,
eflux time, CEAP class, and VCSS.
Results: The average patient age was 51 and 81% were female. VCSS
cores ranged from 2 to 15 and CEAP ranged between 2 and 6. Mean
eflux time was 5.9 seconds (0.9-12) and the GSV diameter mean was 7.7
m (2.6-19). Statistical analysis showed there was no significant rela-
ionship between reflux time and vein diameter (r  .148). A moderate
orrelation existed between vein diameter and both CEAP and VCSS
cores (r .382 and 0.419, respectively; P .01). No correlation existed
etween reflux time and CEAP/VCSS scores (r  .103 and 0.082,
espectively).
Conclusions: In our population, there was no relationship between
eflux time and CEAP/VCSS scores, and only a moderate relationship
etween GSV diameter and these physician-derived scores. Using GSV
iameter and/or reflux times alone as surrogate markers for disease
everity may be inappropriate. This abstract addresses the relationship
etween ultrasound scan findings and CEAP/VCSS scores. Patient out-
ome can improve if we fully understand the criteria used to measure
isease severity.
lack Patients Are Less Likely to Receive First Time Arteriovenous
istulas: A Question of Smaller Vein Diameters
randon Ishaque, Mohamed A. Zayed, MD, PhD, Jessica Miller, Amy H.
aji, MD, PhD, Jason T. Lee, MD, Jessica O’Connell, MD, and Christian de
irgilio, MD, Department of Surgery, University of California – Los Ange-
es, Los Angeles, Calif.
